| 1. The CMO (Chief Medical Officer) position, which has been vacant for over two years, is held byNHGRIDirector Eric D. Green, Ph.D. takes over (National Human Genome Research)；2, CCO (Chief Commercial Officer) Everett Cunningham has left the position,Serve asQuanterix CEO。"This is fucking blooming in both sequencing and proteomics..."If you don't want to save effort, follow my lead and let's comb through some details together.As资深老粉都知道, Illumina's CMO has been vacant for a long time.In August 2023, Dr. Phillip G. Febbo left the position of CMO at Illumina, Inc.Subsequently, the position has remained vacant.An interesting detail is that prior to this, Phillip was the CMO of Genomic Health.Subsequently, this company was later acquired by a well-known company in the industry.Exact SciencesAcquisition, consideration of $2.8 billion, Oncotype DX is the company's core asset.This wait will last for more than two years, until January 8, 2026.Illumina, Inc. announced on the same day that Dr. Eric D. Green, former director of the National Human Genome Research Institute (NHGRI), will serve as the company's Chief Medical Officer (CMO).Dr. Eric D. Green was born on October 10, 1959, in St. Louis, Missouri, USA.His father, Maurice Green, is a virologist at the Saint Louis University School of Medicine, and his younger brother, Michael Green, is a molecular biologist.Eric holds an M.D. and Ph.D. from the University of Washington. In 1992, he joined the Human Genome Center at the University of Washington, and later moved to the National Human Genome Research Institute (NHGRI).In 1996, Eric became the head of the Genome Technology Division at NHGRI, and in 1997, he served as the Director of the NIH Intramural Sequencing Center and the Scientific Director of NHGRI.In 2009, Eric wasFrancis CollinsAppointed as the Director of NHGRI until March 2025.With such a resume, serving as the CMO of a sequencing company would be absolutely no problem.Although Eric has no prior experience working in the industry, his strong academic background and network are likely what Illumina values.Along with the announcement of the CMO appointment, there has been a change in Illumina's CCO position—Everett Cunningham has stepped down and joined a life science tools company as CEO.This paragraph is quite interesting, CEOJacob Thaysen stated:"We thankEverettThe leadership demonstrated during the company's critical transition period.Looking ahead, we already have a strong leadership team.", making outstanding progress continuously in achieving long-term goals and being highly confident in the company’s development path.”In fact, Everett Cunningham only joined Illumina in June 2024, making it a total of just one and a half years at most.Uh, is this guy here for a transitional period at Illumina, Inc....?Before joining Illumina, Inc., he wasExact SciencesCCO, can be considered as a colleague of Dr. Phillip G. Febbo, former CMO of Illumina (callback, right?).What a coincidence! Our old friend Quanterix announced on the same day that Everett Cunningham will serve as the company's CEO and President, and join the board of directors.Everett CunninghamWill officially take office on January 19, 2026. Current CEO Masoud Toloue may ensure a smooth transition by serving in an advisory role or other capacities at that time.Masoud Toloue assumed the position at Quanterix on April 25, 2022, and his previous company was PerkinElmer.Masou led the merger of Quanterix and Akoya, but did not mention the next one.A reasonable guess is... the acquisition of Akoya is Zhuren's task? Just kidding...Originally, the executives from Illumina's Francis deSouza era were almost entirely replaced by the "new king," and now the CCO has left as well.According to the announcement, CEO Jacob will temporarily assume the duties of CCO until a new successor is found.You say, does this mean that the original CCO team now has the opportunity to reach the "highest authority"?On that day, the stocks of the two companies fluctuated slightly.It seems that I have resorted to clickbait...It seems that Quanterix is really "farewelling" the old CEO... Hahaha~Note 1: https://investor.illumina.com/news/press-release-details/2026/Illumina-Appoints-Dr--Eric-Green-as-Chief-Medical-Officer/default.aspxNote 2: https://ir.quanterix.com/news-releases/news-release-details/quanterix-appoints-everett-cunningham-president-and-ceoThe article is sourced fromTrace the Cause and Capture the Drug`, Author`Star Sea Navigator | 
